Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1988
Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brainP C Waldmeier, M Williams, P A Baumann, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 AP C Waldmeier, K H Antonin, J J Feldtrauer, et al.
Neuroscience Letters|March 28, 1986
Glutamate-induced activation of rat locus coeruleus increases CA1 pyramidal cell excitabilityH R Olpe, J Laszlo, M F Pozza, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1990
CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structureP C Waldmeier, P A Baumann, J J Feldtrauer, et al.
Nuclear Medicine and Biology|April 1, 1996
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase AS M Ametamey, H F Beer, I Guenther, et al.
European Journal of Pharmacology|December 29, 1998
Morpholin-2-yl-phosphinic acids are potent GABA(B) receptor antagonists in rat brainJ Ong, D I Kerr, H Bittiger, et al.
Neurochemical Research|November 1, 1993
Clinical pharmacology of the new COMT inhibitor CGP 28,014P R Bieck, K H Antonin, G Farger, et al.
The Journal of Cell Biology|January 3, 2001
Transgenic activation of Ras in neurons promotes hypertrophy and protects from lesion-induced degenerationR Heumann, C Goemans, D Bartsch, et al.
Pageof 8